The risk of developing Alzheimer's disease in older people who were exposed to COVID-19 was 50% to 80% higher than in the control group.

According to a study published today in the Journal of Alzheimer's Disease, people 65 and older who contracted COVID-19 were more likely to develop Alzheimer's disease. The highest risk was seen in women over the age of 85.

Over a one-year period, the risk for Alzheimer's disease in older people nearly doubled after they were exposed to COVID. The researchers don't know if COVID-19 causes new development of Alzheimer's disease or if it makes it worse.

The factors that play into the development of Alzheimer's disease have been poorly understood.

She wanted to see if COVID could lead to increased diagnoses since it has been associated with central nervous system abnormality.

The research team analyzed the electronic health records ofPukiWikiPukiWikiPukiWikirs, who were 65 and older, and found that they had no prior diagnosis of Alzheimer's disease.

They divided the population into two groups, one consisting of people who contracted COVID-19 and the other of people who had no documented cases of the disease. More than half a million people were in the non-infecting group.

"If this increase in new diagnoses of Alzheimer's disease is sustained, the wave of patients with a disease currently without a cure will be substantial, and could further strain our long-term care resources." Reducing general risk factors such as hypertension, heart disease, Obesity and a sedentary lifestyle was thought to have turned some of the tide onAlzheimer's disease. Many people in the U.S. have had Covid and the long-term consequences are still emerging. It's important to keep an eye on the impact of this disease.

The team plans to continue studying the effects of COVID-19 on Alzheimer's disease and other neurodegenerative disorders

People with dementia are twice as likely to contract COVID, people with substance abuse disorder orders are more likely to contract COVID, and people who take Paxlovid for treatment of COVID symptoms experience rebound infections.

There is a story

The materials are provided by the university. The content can be edited for style and length.